MedTrace Logo

Combination Treatment for Advanced Liver Cancer

NCT02149771 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2018-04-19

No results posted yet for this study

Summary

The purpose of this study is to determine whether TACE combined endovascular stent implantation confers a survival benefit over TACE alone.

Conditions

Interventions

PROCEDURE

chemoembolization

Conventional chemoembolisation by administering Doxorubicin and Oxaliplatin mix with 5-20 mL iodised oil.Gelatine sponge was used to embolise the feeding artery of the tumour.Repeat if patients with viable lesions demonstrated by CT or MRI.

DEVICE

endovascular stents implantation

Bare stents implant within portal vein.

PROCEDURE

iodine-125 seed strand implantation

Iodine-125 seed strand implant within portal vein.

Sponsors & Collaborators

  • Shanghai Municipal Science and Technology Commission

    collaborator OTHER_GOV

  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Zhinping Yan, MD · Department of Interventional Radiology, Zhongshan Hospital, Fudan University

  • Jianjun Luo, MD · Department of Interventional Radiology, Zhongshan Hospital, Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2016-05-31
Completion
2016-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02149771 on ClinicalTrials.gov